In addition, IGF2BP3 and METTL3 improve the expression of transcription factor HDGF by directly recognizing and binding the m6A-modified HDGF, which transcriptionally accelerates the expression of GLUT4 and ENO2 to facilitate glycolysis in gastric cancer. Here, IGF2BP3 is linked to gastric cancer.